Roche Holding AG's Fiscal Year is From January To December - All Figures are in Percent.
The item "Return-On-Equity" stands at 37.88 percent as of 06/30/2025, the lowest value at least since 03/31/2022, the period currently displayed.
As of the end of Roche Holding AG's second quarter, the item "Return On Equity" stands at 37.88 Percent. This represents a decrease of -16.66 percentage points compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -35.03 percentage points compared to the value the year prior.
The 1 year change in percentage points is -35.03.
The 3 year change in percentage points is -80.14.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Return On Equity | 905,699,262,464.00 |
![]() | Johnson & Johnson - Return On Equity | 486,508,953,600.00 |
![]() | AbbVie Inc - Return On Equity | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Return On Equity | 280,205,508,085.11 |
![]() | Novartis AG - Return On Equity | 255,096,620,580.91 |